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The reactivity of 2-trichloromethylbenzoxazoles towards 
various nucleophiles, under metal free or iron-catalyzed 
conditions, for the synthesis of substituted benzoxazoles is 
described. These methods allow for selective substitution at 
either the 2- or 2’- position of the benzoxazoles using the 
same starting materials / reagents. This approach allows for 
the controlled synthesis of a variety of key derivatives from 
a single 2-trichloromethylbenzoxazole starting material. 
 
The benzoxazole motif has been incorporated into a number 
of pharmaceuticals, agrochemicals and materials that are vital 
to our everyday lives.1 Due to the importance of benzoxazoles, 
widespread research has been conducted on their synthesis2 
and subsequent functionalization.3 The selective synthesis of 
2-amino- or 2-amidobenzoxazoles from both activated 
substrates4,5 and via C-H6,7 activation has been extensively 
developed (Scheme 1a/b).4a,5b Due to the nature of the methods 
used for their synthesis either the 2-amino- or 2-
amidobenzoxazoles can be accessed, but generally not both 
from the same starting materials using the same reagents. 
Additionally, in order to mitigate the negative environmental 
and cost implications of noble metal catalysts, there has been a 
recent push to develop metal free or base metal-catalyzed 
methods.8,9 Thus an opportunity exists to develop selective 
synthetic methods for the derivatization of this important 
scaffold. Previously, we showed that 2-
trichloromethylbenzoxazoles 1 could be synthesized via a 
mild, metal free reaction between trichloroacetonitrile10 and 2-
aminophenols 4 in methanol at 40 °C (cf. Scheme 2).11,12 
Whilst the reactivity of some 2-trichloromethylazoles has been 
investigated,13 little work on the reactivity of 2-
trichloromethylbenzoxazoles has been reported.14 Herein we 
report our findings into controlling the reactivity of 2-
trichloromethylbenzoxazoles for the selective synthesis of 2-
amino- or 2-amidobenzoxazoles as well as other derivatives in 
which the carbon of the trichloromethyl moiety is either 
extruded or retained (Scheme 1c). 
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Scheme 1. Methods of benzoxazole functionalization 
 
Due to the importance of 2-aminobenzoxazoles, the study 
began with the direct displacement of the 2-trichloromethyl 
moiety from 2-(trichloromethyl)benzo[d]oxazole 1 with an 
amine nucleophile.15 Initial reactions resulted in a mixture of 
2-amino- and 2-amidobenzoxazoles. After screening a variety 
of Lewis acids, which were hoped to activate the C-2 position 
towards nucleophilic aromatic substitution, as well as solvents, 
temperatures and times it was found that the key parameters 
for controlling the product distribution between amine 2 and 
amide 5 were the molarity of the system and water content.16 
Thus, reaction of 2-trichloromethylbenzoxazole 1 with 
pyrrolidine (1.1 equiv.) in dry acetonitrile (1 M, relative to the 
benzoxazole) at 60 °C for 4 h afforded the desired 2-
(pyrrolidin-1-yl)benzo[d]oxazole (2) in excellent yield. The 
reaction could also be run at rt, though required 13 h to go to 
completion, or in the presence of the nucleophilic catalysts 
DABCO,17 which led to slightly improved yields (cf. Scheme 
3). Interestingly, based on pKaH values the reaction should  
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Scheme 2. DOS approach to the functionalization of 2-(trichloromethyl)benzo[d]oxazole (1) 
 
 
not proceed (cf. Scheme S1).18 It is believed that the liberated 
chloroform decomposes under the reaction conditions to form 
a reactive carbene intermediate, which then decomposes and 
thus shifts the reaction equilibrium towards the 2-amino 
product 2.19  
 
Building upon the selective C-2 substitution of an amine 
nucleophile, the addition of an alkoxide,20 generated in situ, to 
the 2-position of the trichloromethylbenzoxazole was 
investigated. It was found that methanol and benzyl alcohol 
could add effectively to 2-(trichloromethyl)benzo[d]oxazole 
(1) in the presence of DBU in acetonitrile to form either 2-
methoxybenzo[d]oxazole (3a) or 2-(benzyloxy)benzo-
[d]oxazole (3b), albeit in moderate yields. It was previously 
reported that strong bases can be used in the addition of 
alcohols to related trichloromethylazoles.13 Unfortunately, 
these conditions did not lead to an improved yield of the 
desired addition adducts. 
 
Having established methods for the direct C-2 substitution 
of 2-trichloromethylbenzoxazoles, the selective C-2’ 
substitution processes were investigated.21 After screening a 
variety of conditions16 it was found that reaction of 2-
(trichloromethyl)benzo[d]oxazole (1) with pyrrolidine (0.9 
equiv.) in wet acetonitrile (0.01 M, relative to the 
benzoxazole) at rt for 76 h afforded the desired 
benzo[d]oxazol-2-yl(pyrrolidin-1-yl)methanone (5) in 66% 
yield. Reducing the reaction time to 19 h gave the product in 
35% yield. These mild conditions are in contrast to related 
amide forming processes from heterocyclic trichloromethyl 
groups that use strong bases, high reaction temperatures or 
toxic solvents to achieve similar transformations.20 They 
therefore should be particularly applicable to substrates that 
are base or thermally unstable. It was also possible to reduce 
the reaction time via the addition of FeCl3 (1.0 equiv.), which 
resulted in the formation of benzo[d]oxazol-2-yl(pyrrolidin-1-
yl)methanone (5) after 19 h in 57% yield. 
 
As part of a substrate scope study (vide infra) it was found 
that the reaction of 2-(trichloromethyl)benzo[d]oxazole (1) 
with pyrrolidine (1.1 equiv.) in acetonitrile (1 M relative to the 
pyrrolidine) at 60 °C for 4 h afforded 7-chloro-2,3-
di(pyrrolidin-1-yl)-2H-benzo[b][1,4]oxazine (6e), the structure 
of which was confirmed by X-ray analysis.22 Gauß and Heitzer 
previously reported a related ring expansion process, though 
they started from 2-dichloromethylbenzoxazoles rather than 2-
trichloromethylbenzoxazole 1.23 Also, Molinski et al. found 
that 2-substituted oxazolines could be converted to 
dihydrooxazinones in the presence of SeO2.24 Interestingly, 
compound 6e could only be formed if a reduction was taking 
place under the reaction conditions, though at which point in 
the process the reduction is taking place is unclear. In related 
work, it was also shown that 2-dichloromethylbenzoxazoles 
can undergo hydrogen / deuterium exchange in the presence of 
triethylamine. 
 
Furthermore, hydrolysis of 2-trichloromethylbenzoxazole 1 
was examined (Scheme 2). It was found that upon treatment of 
2-(trichloromethyl)benzo[d]oxazole (1) with FeCl2 (2 mol %) 
and H2O (2.5 equiv.)25 that ring opened 2,2,2-trichloro-N-(2-
hydroxyphenyl) acetamide (7) was formed in good yield. The 
connectivity of acetamide 7 was confirmed by X-ray 
analysis.22 Acetamide 7 and related analogues have previously 
been shown to have germination inhibition activity against 
lettuce seeds.26 A screen of hydrolysis condition was 
undertaken to investigate this process further. It was found 
that the best non-metal containing process for the hydrolysis 
was to heat 2-trichloromethylbenzoxazole 1 in H2O at 150 °C 
for 2 h. This method gave the desired 2,2,2-trichloro-N-(2-
hydroxyphenyl) acetamide (7) in a moderate 37% yield.22  
 
 
3  
In efforts to optimize the addition reactions and control the 
C-2 vs. C-2’ selectivity a variety of Lewis acids were 
screened.22 During the course of this study it was found that 
the reaction of 2-trichloromethylbenzoxazole (1) with 
pyrrolidine (1.1 equiv.) in the presence of FeCl3 afforded 
bisbenzoxazole 8 in moderate yield. The structure of this 
novel compound was confirmed by 2D NMR analysis and X-
ray crystallography.22 
 
With the optimized conditions in hand for the synthesis of 
2-aminobenzoxazoles, the effect of substitution on the 
benzoxazole ring was investigated to assess the effect of 
electronic factors on the formation of 2-aminobenzoxazoles 2 
from 2-trichloromethylbenzoxazoles 1 (Scheme 3). Thus, 
reaction of 2-(trichloromethyl)benzo[d]oxazole (1a) with 
pyrrolidine (1.1 equiv.) at either 60 °C / rt afford 2-
(pyrrolidin-1-yl)benzo[d]oxazole (2a) in excellent yield. The 
addition of the nucleophilic catalyst DABCO (10 mol %) lead 
to a slight increase in yield of 2-aminobenzoxazole 2a.17 The 
annulation of an aromatic ring to the starting material lead to 
an increased yield of 2-(pyrrolidin-1-yl)naphtho[2,3-d]oxazole 
(2b). Interestingly, having an electron rich methoxy moiety in 
the system resulted in a decrease in yield of 2c relative to the 
electron deficient 5- and 6-chloro derivatives, 2d and 2e. As 
mentioned previously, the mass balance in the reaction of the 
chloro-substituted benzoxazoles 1d / 1e are the ring opened 
species 6d / 6e (cf. Scheme 2). 
 
In conclusion, an investigation into the reactivity of 2-
trichloromethylbenzoxazole towards various nucleophiles 
under metal free or iron-catalyzed conditions was conducted. 
The newly developed methods allow for the controlled 
synthesis of a variety of benzoxazole derivatives starting from 
the same starting material. Importantly, these methods allow 
for substitution at either the 2- or 2’- position of the 
benzoxazoles by simply altering the reactant concentration / 
water content. Thus a variety of derivatives can be synthesized 
from a simple 2-trichloromethylbenzoxazole starting material 
via this diversity-oriented synthesis (DOS)27 type approach. 
EXPERIMENTAL SECTION  
General Remarks. Unless otherwise indicated, all 
commercially available reagents and solvents were used 
directly from the supplier without further purification. 
Solvents used for column chromatography were of technical 
grade. Column chromatography was performed on silica gel 
(60-120) mesh. Visualization was accomplished with UV light 
and a potassium permanganate solution. 1H NMR and 13C 
NMR were recorded at ambient temperature using CDCl3 
(7.26 ppm). Chemical shift values are expressed as parts per 
million (ppm) and J values are in Hertz. Splitting patterns are 
indicated as s: singlet, d: doublet, t: triplet, q: quartet or 
combination, br.s broad singlet or m: multiplet. The melting 
points reported are uncorrected. Infrared spectra were 
recorded as diluted solutions, in spectroscopic grade 
chloroform unless otherwise stated. Absorption maxima (λ 
max) of major peaks are reported in wavenumbers (cm-1), 
quoted to the nearest integral wavenumber. Reactions were 
run in a sealed microwave reaction vessel and heated using an 
aluminium block on a hot plate. 
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Scheme 3. Addition of pyrrolidine to substituted 2-
trichloromethylbenzoxazoles 
 
2-(Pyrrolidin-1-yl)benzo[d]oxazole (2a)28 Method A: To a 
stirred solution of 2-(trichloromethyl)benzo[d]oxazole (1a, 
200 mg, 0.8 mmol) in dry acetonitrile (1 M) at r.t. was added 
pyrrolidine (79 µL, 0.9 mmol). The resultant solution was 
stirred at 60 °C for 4 h. The solvent was removed in vacuo and 
the residue was purified by flash column chromatography on 
silica gel (5% ethyl acetate in petroleum ether) to afford 2-
(pyrrolidin-1-yl)benzo[d]oxazole (2a, 146 mg, 92% yield) as a 
yellow solid. Method B: To a stirred solution of 2-
(trichloromethyl)benzo[d]oxazole (1a, 200 mg, 0.8 mmol) in 
dry acetonitrile (1 M) at r.t. was added pyrrolidine (79 µL, 0.9 
mmol). The resultant solution was stirred at r.t. for 13 h. The 
solvent was removed in vacuo and the residue was purified by 
flash column chromatography on silica gel (5% ethyl acetate 
in petroleum ether) to afford 2-(pyrrolidin-1-
yl)benzo[d]oxazole (2a, 143 mg, 90% yield) as a yellow solid. 
Method C: To a stirred solution of 2-
(trichloromethyl)benzo[d]oxazole (1a, 100 mg, 0.42 mmol) in 
dry acetonitrile (1 M) at r.t. were added pyrrolidine (40 µL, 
0.47 mmol) and DABCO (4.7 mg, 0.042 mmol). The resultant 
solution was stirred at 60 °C for 4 h. The solvent was removed 
in vacuo and the residue was purified by flash column 
chromatography on silica gel (5% ethyl acetate in petroleum 
ether) to afford 2-(pyrrolidin-1-yl)benzo[d]oxazole (2a, 75 
mg, 95% yield) as a yellow solid. m.p. 133 – 135 °C (lit. m.p. 
136 –137 °C); Rf = 0.25 (1:9 ethyl acetate:petroleum ether); IR 
(CHCl3) n(cm-1) 3011, 2978, 2880, 1648; 1H NMR (300 MHz, 
CDCl3, 298 K) δH 7.36 (1H, d, J = 7.8 Hz), 7.26 (1H, d, J = 
7.8 Hz), 7.15 (1H, apparent td, J = 7.7, 1.2 Hz), 6.99 (1H, 
apparent td, J = 7.7, 1.2 Hz), 3.69 – 3.62 (4H, m), 2.07 – 2.01 
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(4H, m); 13C{1H} NMR (75 MHz, CDCl3, 298 K) δc 160.9, 
148.9, 143.5, 123.6, 119.9, 115.8, 108.4, 47.2 (2C), 25.4 (2C); 
HRMS (ESI) m/z: calculated for [M+H]+, C11H13N2O+, 
189.1023, found: 189.1030. 
 
2-(Pyrrolidin-1-yl)naphtho[2,3-d]oxazole (2b) To a stirred 
solution of 2-(trichloromethyl)naphtho[2,3-d]oxazole (1b, 158 
mg, 0.55 mmol) in dry acetonitrile (1 M) at r.t. was added 
pyrrolidine (51µL, 0.6 mmol). The resultant solution was 
stirred at 60 °C for 4 h. The solvent was removed in vacuo and 
the residue was purified by flash column chromatography on 
silica gel (5% ethyl acetate in petroleum ether) to afford 2-
(pyrrolidin-1-yl)naphtho[2,3-d]oxazole (2b, 130 mg, 99% 
yield) as a yellow oil. IR (CHCl3) n(cm-1) 2969, 2881, 1656; 
1H NMR (300 MHz, CDCl3, 298 K) δH 7.86 – 7.80 (2H, m), 
7.68 (1H, s), 7.58 (1H, s), 7.37 (2H, quind, J = 6.9, 1.3 Hz), 
3.66 (4H, t, J = 6.7 Hz ), 2.05 – 1.97 (4H, m); 13C{1H} NMR 
(75 MHz, CDCl3, 298 K) δc 161.9, 149.3, 144.1, 131.9, 129.2, 
127.6, 127.5, 124.2, 123.5, 111.4, 104.3, 47.5 (2C), 25.5 (2C); 
HRMS (ESI) m/z: calculated for [M+H]+, C15H15N2O+, 
239.1179, found: 239.1189. 
 
5-Methoxy-2-(pyrrolidin-1-yl)benzo[d]oxazole (2c)29 To a 
stirred solution of 5-methoxy-2-(trichloromethyl) 
benzo[d]oxazole (1c, 147 mg, 0.55 mmol) in dry acetonitrile 
(1 M) at r.t. was added pyrrolidine (51 µL, 0.6 mmol). The 
resultant solution was stirred at 60 °C for 4 h. The solvent was 
removed in vacuo and the residue was purified by flash 
column chromatography on silica gel (5% ethyl acetate in 
petroleum ether) to afford 5-methoxy-2-(pyrrolidin-1-
yl)benzo[d]oxazole (2c, 83 mg, 69% yield) as a light brown 
crystals. IR (CHCl3) n(cm-1) 2957, 2880, 1650; 1H NMR (300 
MHz, CDCl3, 298 K) δH 7.10 (1H, d, J = 8.6 Hz), 6.92 (1H, d, 
J = 2.5 Hz), 6.53 (1H, dd, J = 8.6, 2.5 Hz), 3.79 (3H, s), 3.64 – 
3.60 (4H, m), 2.04 – 1.99 (4H, m); 13C{1H} NMR (75 MHz, 
CDCl3, 298 K) δc 161.8, 156.9, 144.7, 143.6, 108.3, 106.3, 
101.2, 55.8, 47.3 (2C), 25.6 (2C); HRMS (ESI) m/z: 
calculated for [M+H]+, C12H15N2O2+, 219.1129, found: 
219.1134. 
 
5-Chloro-2-(pyrrolidin-1-yl)benzo[d]oxazole (2d)29 To a 
stirred solution of 5-chloro-2-(trichloromethyl) 
benzo[d]oxazole (1d, 150 mg, 0.55 mmol) in dry acetonitrile 
(1 M) at r.t. was added pyrrolidine (51 µL, 0.6 mmol). The 
resultant solution was stirred at 60 °C for 4 h. The solvent was 
removed in vacuo and the residue was purified by flash 
column chromatography on silica gel (5% ethyl acetate in 
petroleum ether) to afford 5-chloro-2-(pyrrolidin-1-
yl)benzo[d]oxazole (2d, 100 mg, 81% yield) as a white solid. 
m.p. 121 – 123 °C; IR (CHCl3) n(cm-1) 2979, 2882, 1650; 1H 
NMR (300 MHz, CDCl3, 298 K) δH 7.28 (1H, d, J = 2.1 Hz), 
7.10 (1H, d, J = 8.4 Hz), 6.90 (1H, dd, J = 8.4, 2.1 Hz), 3.60 
(4H, t, J = 6.7 Hz), 2.05 – 1.96 (4H, m); 13C{1H} NMR (75 
MHz, CDCl3, 298 K) δc 161.6, 147.5, 145.0, 128.9, 119.6, 
115.8, 108.9, 47.3 (2C), 25.4 (2C); HRMS (ESI) m/z: 
calculated for [M+H]+, C11H12ClN2O+, 223.0633, found: 
223.0637. 
 
6-Chloro-2-(pyrrolidin-1-yl)benzo[d]oxazole (2e) To a 
stirred solution of 6-chloro-2-(trichloromethyl) 
benzo[d]oxazole (1e, 150 mg, 0.55 mmol) in dry acetonitrile 
(1 M) at r.t. was added pyrrolidine (51 µL, 0.6 mmol). The 
resultant solution was stirred at 60 °C for 4 h. The solvent was 
removed in vacuo and the residue was purified by flash 
column chromatography on silica gel (5% ethyl acetate in 
petroleum ether) to afford 6-chloro-2-(pyrrolidin-1-
yl)benzo[d]oxazole (2e, 93 mg, 75% yield) as a white solid. 
m.p. 126 – 128 °C; IR (CHCl3) n(cm-1) 2979, 2881, 1651; 1H 
NMR (300 MHz, CDCl3, 298 K) δH 7.22 – 7.19 (2H, m), 7.08 
– 7.00 (1H, m), 3.62 – 3.58 (4H, m), 2.05 – 1.96 (4H, m); 
13C{1H} NMR (75 MHz, CDCl3, 298 K) δc 161.2, 149.1, 
142.6, 125.0, 124.0, 116.1, 109.3, 47.4 (2C), 25.5 (2C); 
HRMS (ESI) m/z: calculated for [M+H]+, C11H12ClN2O+, 
223.0633, found: 223.0639. 
 
2-Methoxybenzo[d]oxazole (3a)30 To a stirred solution of 2-
(trichloromethyl)benzo[d]oxazole (1a, 150 mg, 0.6 mmol, 1 
equiv.) in acetonitrile (0.6 mL, 1 M) at ambient temperature 
were added methanol (28 µL, 0.7 mmol, 1.1 equiv.) and DBU 
(104 µL, 0.7 mmol, 1.1 equiv.). The resultant solution was 
stirred at 60 ºC for 16 h. The mixture was allowed to cool to 
r.t. and filtered through silica (dichloromethane). The solvent 
was removed in vacuo and the residue was purified by flash 
column chromatography on base washed silica gel (3% ethyl 
acetate in petroleum ether) to afford 2-
methoxybenzo[d]oxazole (3a, 24 mg, 25%) as a clear oil. Rf = 
0.50 (1:2 ethyl acetate:petroleum); IR (CHCl3) n(cm-1) 3156, 
2927, 2254, 1792, 1747, 1552; 1H NMR (300 MHz, CDCl3, 
298 K) δH 7.90 (1H, d J = 7.9 Hz) 7.67 (1H, d J = 8.1 Hz), 
7.56 – 7.44 (2H, m), 4.10 (3H, s); 13C{1H} NMR (75 MHz, 
CDCl3, 298 K) δc 156.9, 150.9, 140.5, 128.3, 125.9, 122.2, 
111.8, 53.7; HRMS (ESI) m/z: calculated for [M+H]+, 
C8H8NO2+, 150.0550, found: 150.0540. 
 
2-(Benzyloxy)benzo[d]oxazole (3b)31 To a stirred solution of 
2-(trichloromethyl)benzo[d]oxazole (1a, 150 mg, 0.6 mmol, 1 
equiv.) in acetonitrile (0.6 mL, 1 M) were added benzyl 
alcohol (73 µL, 0.7 mmol, 1.1 equiv.) and DBU (104 µL, 0.7 
mmol, 1.1 equiv.). The resultant solution was stirred at 60 ºC 
for 16 h. The mixture was allowed to cool to r.t. and filtered 
through silica (dichloromethane). The solvent was removed in 
vacuo and the residue was purified by flash column 
chromatography on base washed silica gel (1% ethyl acetate in 
petroleum ether) to afford 2-(benzyloxy)benzo[d]oxazole (3b, 
37 mg, 26%) as a clear oil. IR (CHCl3) n(cm-1) 3009, 2928, 
2855, 1741, 1613, 1568; 1H NMR (300 MHz, CDCl3, 298 K) 
δH 7.81 – 7.79 (2H, m) 7.64 – 7.62 (2H, m), 7.47 (2H, 
apparent td, J = 7.7, 1.4 Hz ), 7.42 – 7.35 (3H, m), 6.87 (2H s); 
13C{1H} NMR (75 MHz, CDCl3, 298 K) δc 159.6, 151.0, 
140.1, 128.6, 128.3, 126.9 (2C), 125.3 (2C), 121.2 (2C), 
119.4, 111.3, 61.0; HRMS (ESI) m/z: calculated for [M+H]+, 
C14H12NO2+, 226.0863, found: 226.0873. 
 
Benzo[d]oxazol-2-yl(pyrrolidin-1-yl)methanone (5) Method 
A: To a stirred solution of 2-(trichloromethyl)benzo[d]oxazole 
(1a, 100 mg, 0.42 mmol) in acetonitrile (0.01 M) at ambient 
temperature was added pyrrolidine (40 µL, 0.47 mmol). The 
resultant solution was stirred at ambient temperature for 76 h. 
The solvent was removed in vacuo and the residue was 
purified by flash column chromatography on silica gel (5% 
ethyl acetate in diethyl ether) to afford benzo[d]oxazol-2-
yl(pyrrolidin-1-yl)methanone (5, 60 mg, 66%) as a yellow 
solid. Method B: To a stirred solution of 2-
(trichloromethyl)benzo[d]oxazole (1a, 100 mg, 0.42 mmol) in 
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acetonitrile (0.01 M) at ambient temperature was added 
pyrrolidine (40 µL, 0.47 mmol). The resultant solution was 
stirred at ambient temperature for 19 h. The solvent was 
removed in vacuo and the residue was purified by flash 
column chromatography on silica gel (5% ethyl acetate in 
diethyl ether) to afford benzo[d]oxazol-2-yl(pyrrolidin-1-
yl)methanone (5, 32 mg, 35%) as a yellow solid. Method C: 
To a stirred solution of 2-(trichloromethyl)benzo[d]oxazole 
(1a, 100 mg, 0.42 mmol) in acetonitrile (0.01 M) at ambient 
temperature were added iron(III)chloride (68 mg, 0.42 mmol) 
and pyrrolidine (40 µL, 0.47 mmol). The resultant solution 
was stirred at ambient temperature for 19 h. The solvent was 
removed in vacuo and the residue was purified by flash 
column chromatography on silica gel (5% ethyl acetate in 
diethyl ether) to afford benzo[d]oxazol-2-yl(pyrrolidin-1-
yl)methanone (5, 52 mg, 57%) as a yellow solid. m.p. 126-128 
ºC; Rf = 0.20 (1:9 ethyl acetate:petroleum ether) IR (CHCl3) 
n(cm-1) 3006, 2886, 1640; 1H NMR (300 MHz, CDCl3, 298 K) 
δH 7.83 (1H, d, J = 7.5 Hz) 7.66 (1H, d, J = 7.6 Hz) 7.48 – 
7.42 (2H, m), 4.14 (2H, t, J = 6.8 Hz), 3.76 (2H, t, J = 6.8 Hz), 
2.11 – 1.93 (4H, m); 13C{1H} NMR (75 MHz, CDCl3, 298 K) 
δc 155.8, 155.3, 150.1, 140.6, 127.2, 125.2, 121.4, 111.7, 49.3, 
47.5, 26.5, 23.9; HRMS (ESI) m/z: calculated for [M+H]+, 
C12H13N2O2+, 217.0972, found: 217.0970. 
 
6-Chloro-2,3-di(pyrrolidin-1-yl)-2H-benzo[b][1,4]oxazine 
(6d) To a stirred solution of 5-chloro-2-(trichloromethyl) 
benzo[d]oxazole (1d, 150 mg, 0.55 mmol) in dry acetonitrile 
(1 M) at r.t. was added pyrrolidine (51 µL, 0.6 mmol). The 
resultant solution was stirred at 60 °C for 4 h. The solvent was 
removed in vacuo and the residue was purified by flash 
column chromatography on silica gel (5% ethyl acetate in 
petroleum ether) to afford 6-chloro-2,3-di(pyrrolidin-1-yl)-2H-
benzo[b][1,4]oxazine (6d, 24 mg, 14% yield) as a yellow 
gummy solid. IR (CHCl3) n(cm-1) 3690, 2929, 2876, 1610; 1H 
NMR (300 MHz, CDCl3, 298 K) δH 7.08 (1H, d, J = 2.1 Hz ), 
6.80 – 6.72 (2H, m), 5.45 (1H, s), 3.65 (3H, br.s), 3.36 (1H, 
br.s) 2.96 – 2.89 (2H, m) 2.68 – 2.61 (2H, m) 1.97 (4H, br.s) 
1.72 – 1.60 (4H, m); 13C{1H} NMR (75 MHz, CDCl3, 298 K) 
δc 152.3, 144.7, 136.0, 125.8, 123.3, 121.9, 115.0, 80.2, 46.7 
(4C), 24.4 (4C); HRMS (ESI) m/z: calculated for [M+H]+, 
C16H21ClN3O+, 306.1368, found: 306.1373. 
 
7-Chloro-2,3-di(pyrrolidin-1-yl)-2H-benzo[b][1,4]oxazine 
(6e) To a stirred solution of 6-chloro-2-(trichloromethyl) 
benzo[d]oxazole (1e, 150 mg, 0.55 mmol) in dry acetonitrile 
(1 M) at r.t. was added pyrrolidine (51 µL, 0.6 mmol). The 
resultant solution was stirred at 60 °C for 4 h. The solvent was 
removed in vacuo and the residue was purified by flash 
column chromatography on silica gel (5% ethyl acetate in 
petroleum ether) to afford 7-chloro-2,3-di(pyrrolidin-1-yl)-2H-
benzo[b][1,4]oxazine (6e, 42 mg, 25% yield) as a yellow 
gummy solid. IR (CHCl3) n(cm-1) 3667, 2974, 2876, 1607; 1H 
NMR (300 MHz, CDCl3, 298 K) δH 7.01 (1H, dd, J = 7.9, 0.7 
Hz ), 6.84 – 6.80 (2H, m), 5.46 (1H, s), 3.63 (3H, br.s), 3.37 
(1H, br.s) 2.96 – 2.88 (2H, m) 2.68 – 261 (2H, m) 2.01 – 1.94 
(4H, m) 1.69 – 1.60 (4H, m); 13C{1H} NMR (75 MHz, CDCl3, 
298 K) δc 151.8, 146.5, 133.5, 126.6, 124.1, 121.3, 114.6, 
80.2, 46.6 (4C), 24.4 (4C); HRMS (ESI) m/z: calculated for 
[M+H]+, C16H21ClN3O+, 306.1368, found: 306.1360. 
 
2,2,2-Trichloro-N-(2-hydroxyphenyl) acetamide (7)32 
Method A: To a stirred solution of 2-
(trichloromethyl)benzo[d]oxazole (1a, 237mg, 1 mmol, 1 
equiv.) and iron(III) chloride (3.0 mg, 0.02 mmol, 2 mol %) in 
acetonitrile (0.2 mL, 5 M) at r.t. was added water (18 µL, 1 
mmol, 1.0 equiv.). The resultant mixture was stirred at r.t. for 
5 h. Water (27 µL, 1.5 mmol, 1.5 equiv.) was added. The 
mixture was stirred at r.t, for 3 h. The solvent was removed in 
vacuo and the residue was purified by flash column 
chromatography on silica gel (5% ethyl acetate in petroleum 
ether) to afford 2,2,2-trichloro-N-(2-hydroxyphenyl) 
acetamide (7, 148 mg, 58%) as a yellow solid. Method B: 2-
(Trichloromethyl)-benzo[d]oxazole (1a, 61 mg, 0.26 mmol) in 
H2O (1.0 mL) was stirred at 150 ºC for 2 h. The solution was 
allowed to cool to r.t. and dichloromethane (10 ml) was added. 
The resultant solution was washed with water (3 x 5 mL). The 
organic layer was dried over magnesium sulfate and the 
solvent was removed in vacuo to afford 2,2,2-trichloro-N-(2-
hydroxyphenyl) acetamide (7, 24 mg, 37%) as a yellow solid. 
m.p. 160 - 161 °C (lit. m.p. 160 °C); IR (CHCl3) n(cm-1) 3594, 
3397, 1720, 1615; 1H NMR (300 MHz, CDCl3, 298 K) δH 8.98 
(1H, br.s) 7.95 (1H, d, J = 8.0 Hz ), 7.13 – 7.09 (1H, m), 7.02 
– 6.93 (2H, m) 5.99 (1H br.s); 13C{1H} NMR (75 MHz, 
CDCl3, 298 K) δc 159.7, 146.1, 126.6, 124.5, 121.7, 121.2, 
116.5, 92.5; HRMS (ESI) m/z: calculated for [M+H]+, 
C8H7Cl3NO2+, 253.9537, found: 253.9534. 
 
 (Z)-2,2'-(1-Chloro-2-(pyrrolidin-1-yl)ethene-1,2-
diyl)bis(benzo[d]-oxazole) (8) To a stirred suspension of 2-
(trichloromethyl)benzo[d]oxazole (1a, 150 mg, 0.6 mmol, 1.0 
equiv.) and iron(III) chloride (97mg, 0.6 mmol, 1.0 equiv.) in 
acetonitrile (6 mL, 0.1 M) at r.t was added pyrrolidine (260 
µL, 3.17 mmol, 5.0 equiv.). The resultant mixture was stirred 
at r.t for 19 h and then filtered through base washed silica. The 
solvent was removed in vacuo and the residue was purified by 
flash column chromatography on silica gel (5% diethyl ether 
in petroleum ether) to afford (Z)-2,2'-(1-chloro-2-(pyrrolidin-
1-yl)ethene-1,2-diyl)bis(benzo[d]oxazole) (8, 58 mg, 26%) as 
a yellow solid. Rf = 0.40 (1:9 ethyl acetate:petroleum);IR 
(CHCl3) n(cm-1) 2982, 2882, 1607, 1578, 1549; 1H NMR (300 
MHz, CDCl3, 298 K) δH 7.80 – 7.77 (1H, m), 7.56 – 7.54 (1H, 
m), 7.44 – 7.39 (3H, m), 7.13 (1H, apparent td, J = 7.7, 1.1 Hz 
), 7.05 (1H, apparent td, J = 7.8, 1.3 Hz ), 6.87 (1H, d, J = 7.8 
Hz ), 3.66 – 3.62 (4H, m), 2.00 – 1.97 (4H, m); 13C{1H} NMR 
(75 MHz, CDCl3, 298 K) δc 161.8, 158.1, 150.5, 150.4, 141.9, 
141.2, 138.6, 126.1, 124.8, 124.1, 124.0, 120.9, 119.3, 111.1, 
109.5, 94.7, 51.3 (2C), 25.6 (2C); HRMS (ESI) m/z: 
calculated for [M+H]+, C20H17ClN3O2+, 366.1004, found: 
366.1000. 
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